Press Releases Anebulo Pharmaceuticals, Inc.

Equities

ANEB

US0345691036

Delayed Nasdaq Other stock markets 10:51:29 2024-05-03 am EDT			5-day change	1st Jan Change
2.92 ^USD	-6.41%		+8.01%	+20.67%

Feb. 13	Anebulo Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	CI
2023	Anebulo Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2023	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2024 Financial Results and Recent Updates	Feb. 13	BU
Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2024 Financial Results and Recent Updates	Nov. 14	BU
Anebulo Pharmaceuticals Announces Appointment of Bimal Shah to its Board of Directors	23-10-09	AQ
Anebulo Pharmaceuticals Announces New CEO	23-10-09	AQ
Anebulo Pharmaceuticals Announces New CEO	23-10-06	BU
Anebulo Pharmaceuticals Announces Appointment of Bimal Shah to its Board of Directors	23-10-06	BU
Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Recent Updates	23-09-20	BU
Anebulo Pharmaceuticals : Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Recent Updates - Form 8-K	23-09-20	PU
Anebulo Pharmaceuticals to Present at Upcoming Investor and Scientific Conferences	23-08-30	BU
Anebulo Pharmaceuticals : Corporate Presentation August 2023	23-08-27	PU
Anebulo Receives Positive Feedback from FDA on Path to Advance Phase 3 Clinical Development of ANEB-001 and Completes Dosing of Phase 2 Extension	23-08-21	BU
ANEBULO PHARMACEUTICALS, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)	23-05-11	AQ
Anebulo Pharmaceuticals Reports Third Quarter Fiscal 2023 Financial Results and Recent Updates	23-05-11	PR
ANEBULO PHARMACEUTICALS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)	23-04-11	AQ
ANEBULO PHARMACEUTICALS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)	23-03-28	AQ
Anebulo Pharmaceuticals Announces Positive Complete Phase 2 Clinical Data Demonstrating Potential of ANEB-001 as a Treatment for Acute Cannabinoid Intoxication	23-03-28	PR
ANEBULO PHARMACEUTICALS, INC. : Entry into a Material Definitive Agreement, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	23-03-08	AQ
Anebulo Pharmaceuticals Expands its Integrated and Outsourced Solutions	23-03-08	PR
Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2023 Financial Results and Recent Updates	23-02-13	AQ
Anebulo Pharmaceuticals Reports Second Quarter Fiscal Year 2023 Financial Results and Recent Updates	23-02-10	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Anebulo Pharmaceuticals, Inc.

Equities

ANEB

US0345691036

Press Releases

Filters